MCL1 and osteosarcoma: Consistent with these results, we observed a reduction in MCL-1 protein levels upon flavopiridol treatment in some of the osteosarcoma cell lines; however, E2F1 protein levels were unaffected in all the osteosarcoma cell lines analyzed (Figure 2D).